Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC-02 in Dry Eye Disease (RAINIER)
NCT03633461Phase 2Completed
- Sponsor
- Oyster Point Pharma
- Start
- Aug 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simpinicline in dry eye disease (DED), sponsored by Oyster Point Pharma. Started Aug 2018; status: completed.
02
Drugs
simpinicline
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03633461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633461.